Skip to main content
Erschienen in: Journal of Cardiothoracic Surgery 1/2019

Open Access 01.12.2019 | Letter to the Editor

Spiral aortoplasty for dilated ascending aorta: a new technique for high-risk patients with combined procedures

verfasst von: Rakan I. Nazer

Erschienen in: Journal of Cardiothoracic Surgery | Ausgabe 1/2019

Abstract

Concomitant replacement of the ascending aorta with the aortic valve in patients who have left ventricular dysfunction might carry high operative risks. Performing the conservative reduction aortoplasty was shown to have less complications in such patients. When combined with other concomitant cardiac procedures, the newly described “spiral” aortoplasty technique in this series allows for a mulitplanar wall tension reduction in moderately dilated ascending aorta.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
AA
Ascending aorta
AAD
Ascending aorta diameter
AI
Aortic regurgitation
AS
Aortic stenosis
AVR
Aortic valve replacement
CABG
Coronary artery bypass grafting
CAD
Coronary artery disease
CHF
Congestive heart failure
LAA
Left atrial appendage
LAD
Left anterior descending
LIMA
Left internal mammary
LV EF
Left ventricular ejection fraction
MR
Mitral regurgitation
OM
Obtuse marginal
PDA
Posterior descending artery
RCA
Right coronary artery
SVG
Saphenous vein graft

Introduction

Ascending aorta dilatation is sometimes concomitantly associated with aortic valve disease. It is generally recommended to surgically intervene on the ascending aorta once the maximum diameter is above 4.5 cm in the setting of other surgical cardiac procedures [1]. This is to avoid the possible risk of future aorta dilatation or the possibility of aortic dissection and rupture [2]. The dilated ascending aorta can be surgically addressed by radical ascending aorta replacement with a tube graft or by the less popular and more conservative reduction aortoplasty, with or without external wrapping [3]. The following sections describes a modified reduction aortoplasty with concomitant cardiac procedures in high risk patients.

Patients

A series of 9 patients are described after local ethical board approval with individual consent for every patient in the series. They had a dilated ascending aortas (4.5 cm to < 5.0 cm) in the setting of concomitant aortic valve replacement with left ventricular dysfunction from July 2016 to December 2018 at our institution. Some patients required additional mitral repair and/or coronary bypass grafting (CABG). All patients successfully underwent “spiral” aortoplasty to reduce the aortic diameter. The ascending aorta was measured for each patient on follow-up at the level of the mid ascending aorta with the use of CT angiography (Table 1).
Table 1
Case series of 9 patients who underwent “spiral” aortoplasty with concomitant aortic valve replacement +/− CABG +/− mitral valve repair
Series no.
Age / Sex
AAD before surgery
LV EF
Diagnosis
Bicuspid aortic valve
Euro Score
Procedure
Follow-up time
Condition on follow-up
1
53 M
4.7 cm
30%
CHF
+
54.50%
Aortoplasty
30 months
Stable. AAD 3.8 cm
   
Severe AI
  
AVR (mosaic #27)
  
   
Moderate MR
  
MV repair (annuloplasty #30)
  
   
Atrial fibrillation
  
MAZE
  
   
Stroke
  
LAA clot extraction and ligation
  
   
Clot in the LAA
     
2
70 M
4.5 cm
25%
CHF
+
20.40%
Aortoplasty
28 months
Stable. AAD 3.6 cm
   
Severe AI
  
AVR (mosaic #27)
  
3
60 M
4.5 cm
35%
Severe AS
 
17.70%
Aortoplasty
25 months
Stable. AAD 3.7 cm
   
CAD: LAD stenosis
  
AVR (mosaic #25)
  
      
CABG: LIMA-LAD
  
4
67 M
4.6 cm
30%
Severe AS
 
20.20%
Aortoplasty
21 months
Stable. AAD 3.8 cm
   
Moderate MR
  
AVR (mosaic #21)
  
   
CAD: LAD stenosis
  
MV repair (annuloplasty #28)
  
      
CABG: LIMA-LAD
  
5
62 F
4.5 cm
40%
Severe AS
+
9.50%
Aortoplasty
17 months
Stable. AAD 3.3 cm
   
Mild MR
  
AVR (mosaic #23)
  
   
CAD: ostial RCA stenosis
  
CABG: SVG-RCA
  
6
55 M
4.8 cm
15%
Severe AI
+
24.00%
Aortoplasty
16 months
Stable. AAD 3.9 cm
   
CAD: 3 vessel disease
  
AVR (mosaic #27)
  
      
CABG: LIMA-LAD, SVG-OM, SVG-PDA
  
7
50 M
4.8 cm
20%
CHF
+
84.70%
Aortoplasty
14 months
AAD 3.7 cm. The patient presented with aortic prosthesis endocarditis and aortic root abscess 10 months after the first operation. He underwent redo surgery with aortic annulus reconstruction and AVR. The patient was discharged on chronic dialysis and died 4 months later due to refractory heart failure.
   
Severe AI
  
AVR (mosaic #27)
 
   
Severe MR
  
MV repair (annuloplasty #30)
 
   
Chronic kidney disease (creatinine 200 μmol/L)
    
8
66 M
4.6 cm
40%
Severe AI
 
12.80%
Aortoplasty
6 months
Stable. AAD 3.5 cm
   
CAD: RCA total occlusion
  
AVR (mosaic #25)
  
      
CABG: SVG-PDA
  
9
72 M
4.5 cm
40%
Severe AS
+
11.00%
Aortoplasty
  
   
CAD: 3 vessel disease
  
AVR (mosaic #23)
4 months
Stable. AAD 3.5 cm
      
CABG: LIMA-LAD, SVG-OM, SVG-PDA
  
AA ascending aorta, AAD ascending aorta diameter, AI aortic regurgitation, AS aortic stenosis, AVR aortic valve replacement, CABG coronary artery bypass grafting, CAD coronary artery disease, CHF congestive heart failure, LAA left atrial appendage, LAD left anterior descending, LIMA left internal mammary, LV EF left ventricular ejection fraction, MR mitral regurgitation, OM obtuse marginal, RCA: right coronary artery, PDA posterior descending artery, SVG saphenous vein graft

Technique

The heart was accessed through a median sternotomy and cardiopulmonary bypass was initiated via central cannulation. The arterial cannula was inserted in the proximal aortic arch. Prior to applying the cross clamp, an umbilical tape was looped around the backside of the ascending aorta and was lifted before applying the cross clamp to ensure the clamp captured the entire aortic wall. The clamp was positioned as high as possible in the ascending aorta. An oblique aortotomy was performed in the middle of the anterior segment of the ascending aorta and was spirally extended downward and laterally toward the non-coronary sinus, stopping at the aortic annulus, and superiorly toward the left shoulder up to the bifurcation of the pulmonary artery. The aortic valve was replaced though this access. Concomitant procedures such as distal coronary grafts and/or mitral repair were performed prior to the aortic procedure. The aortotomy closure was sandwiched between 2 strips of Teflon felt and sutured together using a double closure technique. The Suture incorporated 0.5 cm of aortic tissue on either side during closure in order to reduce the aortic size by 1 cm. (Fig. 1).

Comments

Fusiform ascending aorta aneurysm is commonly observed in patients with aortic valve disease, particularly in those with a bicuspid aortic valve. The dilatation is likely due to intrinsic factors harbored within the connective tissue of the aortic wall. The multiplanar dilatation causes elongation and circumferential expansion of the aorta. Previously described reduction aortoplasty techniques primarily reduce the aortic diameter and wall tension at a single plane in the mid-anterior wall of the ascending aorta [4]. The technique described in this series has the same advantages of other described aortoplasty approaches in high-risk patients with the added advantage of reducing the wall tension and size along the circumferential and longitudinal planes. External wrapping was avoided because of the reported risks of “under-the-wrap” aortic atrophy and rupture, wrap migration, and the need to construct proximal coronary anastomosis in the ascending aorta. Bicuspid aortic valve was present in over half of the series. All patients showed an approximately 1-cm reduction of the mid-ascending aortic diameter on echocardiographic and tomographic follow-up. This technique should not be used in patients with dilated aortic root, ascending aortas with a diameter of > 5.0 cm, in patients with acute aortic dissection, or in patients with syndromic connective tissue disorders such as Marfan’s syndrome. The series is limited by its small size, short follow-up, and the potential risk for re-dilatation of the ascending aorta.
In summary, this series describes a limited number of high risk patients who successfully underwent concomitant aortic valve replacement with reduction aortoplasty and other added procedures. The spiral aortoplasty technique has the advantage of multiplanar aortic size reduction without the need to perform the more radical ascending aorta replacement in moderately dilated ascending aorta.

Acknowledgments

This project was supported by College of Medicine Research Centre, Deanship of Scientific Research, King Saud University.
The series was approved via The Institutional Review Board for the King Saud University College of Medicine (E-19-3849).
Consent was obtained for publication from each patient in the series.

Competing interests

The author declares that he has no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation. 2010;121(13):e266–369.PubMed Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation. 2010;121(13):e266–369.PubMed
2.
Zurück zum Zitat Borger MA, Preston M, Ivanov J, Fedak PW, Davierwala P, Armstrong S, et al. Should the ascending aorta be replaced more frequently in patients with bicuspid aortic valve disease? J Thorac Cardiovasc Surg. 2004;128(5):677–83.CrossRef Borger MA, Preston M, Ivanov J, Fedak PW, Davierwala P, Armstrong S, et al. Should the ascending aorta be replaced more frequently in patients with bicuspid aortic valve disease? J Thorac Cardiovasc Surg. 2004;128(5):677–83.CrossRef
3.
Zurück zum Zitat Liu S, Shi Y, Liu R, Tong M, Luo X, Xu J. Early prognosis of reduction ascending Aortoplasty in patients with aortic valve disease: a single Center's experience. Ann Thorac Surg. 2017;103(2):511–6.CrossRef Liu S, Shi Y, Liu R, Tong M, Luo X, Xu J. Early prognosis of reduction ascending Aortoplasty in patients with aortic valve disease: a single Center's experience. Ann Thorac Surg. 2017;103(2):511–6.CrossRef
4.
Zurück zum Zitat Robicsek F, Cook JW, Reames MK Sr, Skipper ER. Size reduction ascending aortoplasty: is it dead or alive? J Thorac Cardiovasc Surg. 2004;128(4):562–70.CrossRef Robicsek F, Cook JW, Reames MK Sr, Skipper ER. Size reduction ascending aortoplasty: is it dead or alive? J Thorac Cardiovasc Surg. 2004;128(4):562–70.CrossRef
Metadaten
Titel
Spiral aortoplasty for dilated ascending aorta: a new technique for high-risk patients with combined procedures
verfasst von
Rakan I. Nazer
Publikationsdatum
01.12.2019
Verlag
BioMed Central
Erschienen in
Journal of Cardiothoracic Surgery / Ausgabe 1/2019
Elektronische ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-019-0960-5

Weitere Artikel der Ausgabe 1/2019

Journal of Cardiothoracic Surgery 1/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.